Activated CD8+ T cells release interferon-gamma, down-regulate the expression of SLC7A11 and SLC3A2, and inhibit the uptake of cystine by lung cancer cells to achieve anti-tumor effects (170). This evidence concerns the gene SLC7A11 and neoplasm.